Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

Byungyoon Yun; Sang Hoon Ahn; Juyeon Oh; Jin Ha Yoon; Beom Kyung Kim

doi:10.1016/j.ejim.2022.07.003

Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin Ha Yoon, Beom Kyung Kim

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	122-125
Number of pages	4
Journal	European Journal of Internal Medicine
Volume	103
DOIs	https://doi.org/10.1016/j.ejim.2022.07.003
Publication status	Published - 2022 Sept

Bibliographical note

Funding Information:
This study was in part supported by Digital Healthcare Research Grant through the Seokchun Caritas Foundation (SCY2105P). The funder had no role in the study design, data collection, analysis, interpretation, or writing of the report.

All Science Journal Classification (ASJC) codes

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejim.2022.07.003

Cite this

@article{19bd0806ad2e4a4a96466b7a24a22664,

title = "Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma",

keywords = "Antiviral therapy, Comparison, Curative treatment, Death, Entecavir, Hepatitis B virus, Hepatocellular carcinoma, Recurrence, Surgery, Tenofovir",

author = "Byungyoon Yun and Ahn, {Sang Hoon} and Juyeon Oh and Yoon, {Jin Ha} and Kim, {Beom Kyung}",

note = "Funding Information: This study was in part supported by Digital Healthcare Research Grant through the Seokchun Caritas Foundation (SCY2105P). The funder had no role in the study design, data collection, analysis, interpretation, or writing of the report. ",

year = "2022",

month = sep,

doi = "10.1016/j.ejim.2022.07.003",

language = "English",

volume = "103",

pages = "122--125",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

AU - Yun, Byungyoon

AU - Ahn, Sang Hoon

AU - Oh, Juyeon

AU - Yoon, Jin Ha

AU - Kim, Beom Kyung

N1 - Funding Information: This study was in part supported by Digital Healthcare Research Grant through the Seokchun Caritas Foundation (SCY2105P). The funder had no role in the study design, data collection, analysis, interpretation, or writing of the report.

PY - 2022/9

Y1 - 2022/9

KW - Antiviral therapy

KW - Comparison

KW - Curative treatment

KW - Death

KW - Entecavir

KW - Hepatitis B virus

KW - Hepatocellular carcinoma

KW - Recurrence

KW - Surgery

KW - Tenofovir

UR - http://www.scopus.com/inward/record.url?scp=85136592299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136592299&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2022.07.003

DO - 10.1016/j.ejim.2022.07.003

M3 - Letter

C2 - 35835625

AN - SCOPUS:85136592299

SN - 0953-6205

VL - 103

SP - 122

EP - 125

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

ER -

Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this